These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1376649)

  • 21. Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
    Kim Y; Park YH; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Lee SG
    Ann Transplant; 2016 Oct; 21():660-667. PubMed ID: 27777395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of transforming growth factor alpha and vascular endothelial growth factor in diagnosis of hepatocellular carcinoma.
    El-Sherif WT; Makhlouf NA; El-Gendi SS; Hassan HI; Herdan OM
    Egypt J Immunol; 2012; 19(2):53-65. PubMed ID: 23885407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma.
    Sharieff S; Burney IA; Salam A; Siddiqui T
    J Pak Med Assoc; 2001 Mar; 51(3):123-4. PubMed ID: 11381826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.
    Jia X; Liu J; Gao Y; Huang Y; Du Z
    Arch Med Res; 2014 Oct; 45(7):580-8. PubMed ID: 25446613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
    Zhao XY; Li N; Ding HG; Jiang FF
    Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
    Tatsuta M; Yamamura H; Iishi H; Kasugai H; Okuda S
    Oncology; 1986; 43(5):306-10. PubMed ID: 2429242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of serum ferritin in primary hepatocellular carcinoma.
    Giannoulis E; Arvanitakis C; Nikopoulos A; Doutsos I; Tourkantonis A
    Digestion; 1984; 30(4):236-41. PubMed ID: 6210220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma osteopontin level as a diagnostic marker of hepatocellular carcinoma in patients with radiological evidence of focal hepatic lesions.
    Khalil A; Elgedawy J; Faramawi MF; Elfert A; Salama I; Abbass A; Elsaid H; Elsebaai H
    Tumori; 2013; 99(1):100-7. PubMed ID: 23549008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma.
    Porta C; De Amici M; Quaglini S; Paglino C; Tagliani F; Boncimino A; Moratti R; Corazza GR
    Ann Oncol; 2008 Feb; 19(2):353-8. PubMed ID: 17962206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
    Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
    Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma.
    Kim SU; Park JH; Kim HS; Lee JM; Lee HG; Kim H; Choi SH; Baek S; Kim BK; Park JY; Kim DY; Ahn SH; Lee JD; Han KH
    Yonsei Med J; 2015 Sep; 56(5):1296-306. PubMed ID: 26256972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma.
    Soliman HH; Nagy H; Kotb N; Alm El-Din MA
    Int J Biol Markers; 2012 Jul; 27(2):e125-31. PubMed ID: 22388957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.